The Latest

  • COUR Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for Myasthenia Gravis
  • Skip to primary navigation
  • Skip to main content
  • Skip to footer
COUR Pharmaceuticals Logo

COUR Pharmaceuticals

  • Our Company
    • Leadership
    • Advisors
    • Partners
    • Contact
  • Our Technology
    • Pipeline
    • Autoimmune Diseases
    • Allergies
    • Rare Diseases
    • Gene Therapy
  • Our Clinical Trials
  • Publications & Media
    • Press Releases
    • Publications
  • Careers

CNP-201 Clinical Trial Peanut Allergy

Purpose

The main aim of the study is to assess if CNP-201 can reduce inflammation in participants with a peanut allergy who are on a peanut-free diet so that they can safely eat peanuts.  All participants will receive CNP-201 or Placebo through the vein on Day 1 and Day 8. 

Key Requirements

Age
16-55 years old

Accepts healthy patients
No, participants must have peanut allergy.

Active Clinical Sites

Allergy and Asthma Medical Group and Research Center

5776 Ruffin Rd,
San Diego, CA 92123

View On Map

Contact Info:
Email: lorinash@allergyandasthma.com
Phone: (1) 858-268-2368 ext 121

Sneeze, Wheeze & Itch Associates, LLC

2010 Jacobssen Drive,
Normal IL 61761

View On Map

Contact Info:
Email: stephanieoliver@asthma2.com
Phone: (1) 309-452-0995

Centricity Research

99 N. Brice Rd, Suite 260,
Columbus, OH 43213

View On Map

Contact Info:
Email: samantha.estrada@centricityresearch.com
Phone: (1) 614-501-6164 ext 2006

Vital Prospects Clinical Research Institute

7307 S. Yale Ave, Suite 200,
Tulsa, OK 74136

View On Map

Contact Info:
Email: Caitlin.sheppard@aaicenter.net
Phone: (1) 918-392-4550 ext 233

Western Sky Medical Research

2121 Wyoming Ave,
El Paso, TX 79903

View On Map

Contact Info:
Email: lherrera@westernskymed.com
Phone: (1) 915-544-2557

Pharmaceutical Research & Consulting, Inc

5499 Glen Lakes, Dr. Suite 200,
Dallas, TX 75231

View On Map

Contact Info:
Email: pharmaceuticalresearchc@gmail.com
Phone: (1) 214-361-5555

Clinical Research Partners LLC

7110 Forest Ave, Suite 201,
Richmond, VA 23226

View On Map

Contact Info:
Email: ako@clinicalresearchrva.com
Phone: (1) 804-250-9867

Seattle Allergy and Asthma Research Institute

9725 Third Ave, NE Suite 500,
Seattle, WA 98115

View On Map

Contact Info:
Email: jfernandez@seattleallergy.org
Phone: (1) 206-525-5520

Quote Block Decoration

How many participants are being enrolled?

The number of total participants to be enrolled in the clinical trial.

Approximately 58 participants.

Are placebos part of the clinical trial?

A placebo often looks like the investigational medication but has no active ingredient in it. It is used to compare against the actual investigational treatment to evaluate effectiveness.

Yes, participants will receive an infusion of either CNP-201 therapy or placebo. Participants who are randomized to placebo may have the opportunity to receive CNP-201 upon completion of the study.

How long is participation in the clinical trial?

The planned length of time each participant will take part in the clinical trial.

Participation in the study is approximately 2 months.

Clinicaltrials.gov

Clinical Trial Identifier

A Clinical Trial Identifier is a unique number assigned to a clinical trial by clinical trial registries around the world.

NCT05250856

Footer

COUR Pharmaceuticals Logo
  • Our Company
  • Our Technology
  • Our Partners
  • Press
  • Careers

©

2023

COUR Pharmaceuticals.
All Rights Reserved.

Privacy Policy • Terms of Use

Back to Top